Diabetic Macular Oedema, Diabetic Retinopathy, Macular Degeneration, Paediatric Ophthalmology, Retina/Vitreous
Diabetic Macular Oedema, Diabetic Retinopathy, Macular Degeneration, Paediatric Ophthalmology, Retina/Vitreous
Late-breaking abstracts from EURETINA 2024: Advances in retinal therapies
The EURETINA 2024 Congress, held in Barcelona from September 19-22, brought together leading experts in ophthalmology to share the latest research and innovative treatments for retinal diseases. Among the highlights were several late-breaking abstracts that showcased promising advances in therapeutics for conditions such as retinopathy of prematurity (ROP), diabetic retinopathy (DR) and age-related macular degeneration (AMD). These studies not only demonstrated the efficacy and safety of novel treatment options but also addressed critical unmet needs in reducing patient burden and improving long-term outcomes.